RE: Main Market... and Just Getting Started?8 Jun 2026 04:30
There’s no doubt ALRT has had a noticeable increase in visibility recently the MoD transparency notice, the pilot contract, and the leadership change are all factual developments that have helped sentiment. The company is indeed Main Market listed, as you point out, which does set it apart structurally from AIM stocks in terms of reporting obligations and governance requirements.
Where things need grounding is the valuation discussion. A move to 20p would imply a market cap north of £500m, which is a very large step up from the current ~£31m valuation shown on the page . For that kind of re‑rating to occur, the company would need to demonstrate:
Clear commercial traction, not just pilots or ecosystem engagement
Meaningful revenue visibility, especially in defence where procurement cycles are long
Execution against the strategy Roughan is putting in place, which is still in its early stages
Evidence that the MoD or other government bodies intend to scale beyond exploratory trials
Those are all possible, but none are guaranteed.
It’s also worth noting that the MoD pilot referenced is small in monetary terms (~£226k) and is explicitly described as a trial rather than a commercial rollout . The significance is validation, not revenue.
The broader sector tailwinds you mention are real defence spending across Europe is rising, and sovereign AI is an area governments are actively exploring. But the market will ultimately want to see contract conversion, not just positioning.
So yes, the ingredients for progress are there, and the leadership team does have relevant experience. But any specific price target, especially one implying a 15–20x increase, depends entirely on execution and contract wins that have not yet materialised.
Sign In
Follow the stocks
